United States · Platforms & data · MarketBeat

Insider Buying: Corvus Pharmaceuticals (NASDAQ:CRVS) Insider Acquires 1,003 Shares of Stock

Published by MarketBeat · United States 22 min ago

MarketBeat

Detailed summary

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Get Free Report) insider Jeffrey Arcara bought 1,003 shares of the stock in a transaction that occurred on Friday, November 13th. The shares were purchased at an average price of $10.54 per share, for a total transaction of $10,571.62. Following the purchase, the insider owned 4,500 shares in the company, valued at $47,430.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.insidertrades.com)

Also worth reading

The Motley Fool

Insider Buying: Corvus Pharmaceuticals (NASDAQ:CRVS) Insider Acquires 1,003 Shares of Stock

Detailed summary

Also worth reading

Why Investors Should Own Businesses That Can Win Under Any Administration

Diamondback nears $5B deal for Double Eagle’s Permian assets, FT reports

‘It leaves me with a sour taste’: My elderly mother gave our cousin $800 for a car repair. Should I be worried?

Lutnick faces questions over Nvidia spy scandal. His sons' firm has ties to the chipmaker

Silver Lake Partners V DE (AIV) sells $23.15M Dell Technologies stock

Goldman Sachs’ calm 2027 forecast comes with a catch